Dr. Shienbaum is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
Pathology Associates of Northeastern Pennsylvania
781 Keystone Industrial Park
Dunmore, PA 18512Phone+1 570-770-6338Fax+1 570-558-4564
Summary
- Experienced physician leader, senior surgical pathologist, cytopathologist, laboratory director, medical educator, mentor, and entrepreneur serving as the President, CEO, and Managing Partner of Pathology Associates of Northeastern Pennsylvania, Ltd and partner and co-owner of Keystone Medical Laboratories, LP.
I also proudly served as the President of the American Osteopathic College of Pathologists.
Education & Training
- Drexel University College of Medicine/Hahnemann University HospitalFellowship, Cytopathology, 1999 - 2000
- Temple University HospitalResidency, Pathology-Anatomic and Clinical, 1995 - 1999
- Philadelphia College of Osteopathic MedicineClass of 1994
Certifications & Licensure
- PA State License 1995 - 2026
- CT State License 2024 - 2025
- NJ State License 2001 - 2025
- NY State License 2010 - 2025
- OH State License 2023 - 2025
- American Board of Pathology Anatomic Pathology & Clinical Pathology
- American Board of Pathology Cytopathology
Awards, Honors, & Recognition
- Top Doctor Pennsylvania Magazine 2023 Best In Pennsylvania Issue, 2023
- Top Doctor - Pennsylvania The Waiting Room Magazine, 2020
- Top Pathologist New Jersey Monthly Magazine, 2019
- Join now to see all
Publications & Presentations
PubMed
- 72 citationsAntibody and lectin target podoplanin to inhibit oral squamous carcinoma cell migration and viability by distinct mechanismsJhon A. Ochoa-Alvarez, Harini Krishnan, John G. Pastorino, Evan Nevel, David J. Kephart
Oncotarget. 2015-03-10 - 36 citationsPodoplanin emerges as a functionally relevant oral cancer biomarker and therapeutic target.Edward P. Retzbach, Stephanie A. Sheehan, Evan Nevel, Amber Batra, Tran Phi
Oral Oncology. 2018-03-01 - 2 citationsMaackia amurensis seed lectin (MASL) ameliorates articular cartilage destruction and increases movement velocity of mice with TNFα induced rheumatoid arthritis.Kelly L Hamilton, Amanda A Greenspan, Alan J Shienbaum, Bradford D Fischer, Andrea Bottaro
Biochemistry and Biophysics Reports. 2022-12-01
Professional Memberships
- College of American PathologistsFellow
- American Society of Clinical PathologyFellow
- American Osteopathic College of PathologistsMember
External Links
- Pathology Associates of Northeastern Pennsylvania/Keystone Medical Laboratorieshttps://pathologyassociatesofnepa.com/home-page
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: